- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Harms
- Generalizability
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Random allocation
Adamson J, Cockayne S, Puffer S, Torgerson
DJ. Review of randomised trials using the post-randomised consent (Zelen's)
design. Contemp Clin Trials 2006; 27(4):305-319.
PMID: 16455306
Altman DG, Dore CJ. Randomisation and baseline comparisons
in clinical trials. Lancet 1990; 335(8682):149-153.
PMID: 1967441
Altman DG. Randomisation. BMJ 1991; 302(6791):1481-1482.
PMID: 1855013
Altman DG, Bland JM. How to randomise. BMJ 1999;
319(7211):703-704.
PMID: 10480833
Altman DG, Bland JM. Treatment allocation by minimisation.
BMJ 2005; 330(7495):843.
PMID: 15817555
Berger VW, Exner DV. Detecting selection bias in randomized
clinical trials. Control Clin Trials 1999; 20(4):319-327.
PMID: 10440559
Bridgman S, Engebretsen L, Dainty K, Kirkley A, Maffulli N.
Practical aspects of randomization and blinding in randomized clinical trials.
Arthroscopy 2003; 19(9):1000-1006.
PMID: 14608321
Carroll D, Tramer M, McQuay H, Nye B, Moore A.
Randomization is important in studies with pain outcomes: systematic review of
transcutaneous electrical nerve stimulation in acute postoperative pain. Br J
Anaesth 1996; 77(6):798-803.
PMID: 9014639
Chalmers I. Assembling comparison groups to assess the
effects of health care. J R Soc Med 1997; 90(7):379-386.
PMID: 9290419
Chalmers I. Why transition from alternation to
randomisation in clinical trials was made. BMJ 1999; 319(7221):1372.
PMID: 10567161
Chalmers TC, Levin H, Sacks HS, Reitman D, Berrier J,
Nagalingam R. Meta-analysis of clinical trials as a scientific discipline. I:
Control of bias and comparison with large co-operative trials. Stat Med 1987;
6(3):315-328.
PMID: 2887023
Chan AW, Altman DG. Epidemiology and reporting of
randomised trials published in PubMed journals. Lancet 2005;
365(9465):1159-1162.
PMID: 15794971
D'Arcy HP. A change in scientific approach: from
alternation to randomised allocation in clinical trials in the 1940s. BMJ 1999;
319(7209):572-573.
PMID: 10463905
Day S. Treatment allocation by the method of minimisation. BMJ 1999; 319:947-948.
Devereaux PJ, Choi PT, El Dika S, Bhandari M, Montori VM, Schunemann
HJ, Garg AX, Busse JW, Heels-Ansdell D, Ghali WA, Manns BJ, Guyatt GH. An
observational study found that authors of randomized controlled trials
frequently use concealment of randomization and blinding, despite the failure
to report these methods. J Clin Epidemiol 2004; 57(12):1232-1236.
PMID: 15617948
Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of
unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials
2006; 27(1):1-12.
PMID: 16236557
Falagas ME, Pitsouni EI, Bliziotis IA. Trends in the methodological quality of published randomized controlled trials on antibacterial agents. Br J Clin Pharmacol 2008; 65(6):942-954.
PMID: 18279480 [New]
Gluud LL. Bias in clinical intervention research. Am J
Epidemiol 2006; 163(6):493-501.
PMID: 16443796
Gross CP, Krumholz HM, Van WG, Emanuel EJ, Wendler D. Does
random treatment assignment cause harm to research participants? PLoS Med 2006;
3(6):e188.
PMID: 16719548
Haag U. Technologies for automating randomized treatment assigment in clinical trials. Drug Information Journal 1998; 32:7-11.
Hemila H. Allocation concealment and blinding: when
ignorance is bliss. Med J Aust 2005; 183(3):165-166.
PMID: 16175687
Juni P, Altman DG, Egger M. Systematic reviews in health
care: Assessing the quality of controlled clinical trials. BMJ 2001;
323(7303):42-46.
PMID: 11440947
Kennedy A, Grant A. Local sealed envelope randomisation in a multicentre trial: a cautionary tale. Second International Conference Scientific Basis of Health Services & Fifth Annual Cochrane Colloquium; 1997 Oct 8 12; Amsterdam, The Netherlands 1997;88.
Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI.
Stratified randomization for clinical trials. J Clin Epidemiol 1999;
52(1):19-26.
PMID: 9973070
Kjaergard LL, Nikolova D, Gluud C. Randomized clinical
trials in HEPATOLOGY: predictors of quality. Hepatology 1999; 30(5):1134-1138.
PMID: 10534332
Kunz R, Vist G, Oxman AD. Randomisation to protect against
selection bias in healthcare trials. Cochrane Database of Systematic Reviews
2007, Issue 2 Art No : MR000012 DOI: 10 1002/14651858 MR000012 pub2 2007.
Pildal J, Chan AW, Hrobjartsson A, Forfang E, Altman DG,
Gøtzsche PC. Comparison of descriptions of allocation concealment in trial
protocols and the published reports: cohort study. BMJ 2005; 330(7499):1049.
PMID: 15817527
Pildal J, Hrobjartsson A, Jørgensen KJ, Hilden J, Altman
DG, Gøtzsche PC. Impact of allocation concealment on conclusions drawn from
meta-analyses of randomized trials. Int J Epidemiol 2007; 36(4):847-857.
PMID: 17517809
Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz
DA, Edwards SJ, Beck SR, Rowley MG. Lay public's understanding of equipoise and
randomisation in randomised controlled trials. Health Technol Assess 2005;
9(8):1-iv.
PMID: 15763039
Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the
quality of randomization from reports of controlled trials published in
obstetrics and gynecology journals. JAMA 1994; 272(2):125-128.
PMID: 8015122
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical
evidence of bias. Dimensions of methodological quality associated with
estimates of treatment effects in controlled trials. JAMA 1995; 273(5):408-412.
PMID: 7823387
Schulz KF. Subverting randomization in controlled trials.
JAMA 1995; 274(18):1456-1458.
PMID: 7474192
Schulz KF. Randomised trials, human nature, and reporting
guidelines. Lancet 1996; 348(9027):596-598.
PMID: 8774577
Schulz KF. Assessing allocation concealment and blinding in
randomized controlled trials: why bother? ACP J Club 2000; 132(2):A11-A12.
PMID: 10750446
Schulz KF. Assessing allocation concealment and blinding in
randomised controlled trials: why bother? Evid Based Nurs 2001; 4(1):4-6.
PMID: 11707879
Schulz KF, Grimes DA. Allocation concealment in randomised
trials: defending against deciphering. Lancet 2002; 359(9306):614-618.
PMID: 11867132
Schulz KF. Assessing allocation concealment and blinding in
randomised controlled trials: why bother? Equine Vet J 2005; 37(5):394-395.
PMID: 16163939
Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method
of minimization for allocation to clinical trials. a review. Control Clin
Trials 2002; 23(6):662-674.
PMID: 12505244
Treasure T, MacRae KD. Minimisation: the platinum standard
for trials?. Randomisation doesn't guarantee similarity of groups; minimisation
does. BMJ 1998; 317(7155):362-363.
PMID: 9694748
Page last edited: 06 May 2009
